- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03411785
Evaluation of the Comprehensive Primary Care Plus (CPC+) Model
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
This project is a large, seven-year mixed-methods evaluation of the Comprehensive Primary Care Plus (CPC+) Model, sponsored by the Centers for Medicare & Medicaid Services (CMS). CPC+ aims to improve the delivery of primary care; patients' cost, service use, and quality of care; and the experiences of patients, practitioners, and staff. It aims to achieve these goals by helping practices transform across five key care delivery functions: (1) access and continuity, (2) care management, (3) comprehensiveness and coordination, (4) patient and caregiver engagement, and (5) planned care and population health.
The national model includes two rounds, each of which will last for five years. Round 1 will take place from January 2017 through December 2021 and Round 2 from January 2018 through December 2022. A total of 2,877 primary care practices are participating in Round 1. The number of Round 2 practices will not be confirmed until September 2017.
From practices that applied to participate, CMS selected those that provide primary care, met specific certified health information technology (health IT) requirements, and were already engaging in certain care delivery activities. The CPC+ model includes two transformation tracks with incrementally advanced care delivery requirements and payment options. Participating practices will receive financial payments from CMS, including a monthly care management fee and prospective performance-based incentive payment, on top of traditional payments. Some practices will also receive some payment that shifts away from fee-for-service. In addition, practices will receive payments from other participating payers, representing a large proportion of their total revenue. CPC+ practices will receive learning support, data feedback, and health IT support to promote transformation.
To estimate the effect of CPC+, the investigators will compare the outcomes over time for CPC+ practices with the outcomes over time for a group of comparison practices. The investigators selected the comparison practices by identifying practices that matched the CPC+ practices on key characteristics. The investigators expect to include up to 8,397 comparison practices in Round 1.
The investigators will estimate the impact of CPC+ on patient outcomes by tracking the patients who are attributed to a study practice based on receiving most of their evaluation and management care from that practice. The investigators expect to include approximately 5,326,531 attributed patients across the CPC+ and comparison practices in Round 1 (the number of attributed patients for the Round 2 practices is to be determined). Analyses of Medicare (and in some regions Medicaid) claims data for patients attributed to the CPC+ and comparison practices will be conducted to estimate impacts on Medicare expenditures, our primary outcome, and service use and quality of care.
The investigators will also estimate the impact of CPC+ on practice care delivery approaches, and patient, practitioner, and staff experience. The investigators will administer a practice survey to the practice managers of all the study practices to track changes in care delivery and practice characteristics. The investigators will measure patient experience through a survey administered to Medicare fee-for-service beneficiaries attributed to the study practices. Changes in work environment and practitioner and staff experience with CPC+ will be measured through a survey of primary care practitioners of the study practices and staff of the CPC+ practices. For the Round 1 practices, the investigators expect to administer 11,244 practice surveys, 20,000 patient surveys, 10,996 practitioner surveys, and 10,429 staff surveys, The sample sizes for surveys for the Round 2 practices are to be determined. Telephone interviews and site visits will be conducted with CPC+ payers; practitioners and staff in the practices, and, if relevant, the systems and medical groups that own them; patients; and other stakeholders to understand what was implemented, and barriers and facilitators to implementation and improved outcomes.
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Unzutreffend
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- All Medicare fee-for-service patients who receive the largest share of their evaluation and management visits from one of the study primary care practices.
- Practice managers, practitioners, and staff of the study primary care practices.
Exclusion Criteria: None
-
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: CPC+ practices
This is the intervention group, and includes the practices that were selected and agreed to participate in the CPC+ model.
|
CPC+ practices receive a monthly care management fee and prospective performance-based incentive payment on top of traditional payments.
Some practices will also receive some payment that shifts away from fee-for-service.
In addition, CPC+ practices will receive learning and health IT support and data feedback to implement processes to meet care delivery requirements and achieve five primary care functions.
|
|
Kein Eingriff: Comparison practices
Comparison practices are the control group.
This group includes practices not participating in the model that were matched to the CPC+ practices and whose outcomes will be compared to those of the CPC+ practices.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Total Part A and Part B claims paid by Medicare in 2017
Zeitfenster: 12 months
|
Total claims paid by Medicare for for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
12 months
|
|
Total Part A and Part B claims paid by Medicare in 2018
Zeitfenster: 24 months
|
Total claims paid by Medicare for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
24 months
|
|
Total Part A and Part B claims paid by Medicare in 2019
Zeitfenster: 36 months
|
Total claims paid by Medicare for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
36 months
|
|
Total Part A and Part B claims paid by Medicare in 2020
Zeitfenster: 48 months
|
Total claims paid by Medicare for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
48 months
|
|
Total Part A and Part B claims paid by Medicare in 2021
Zeitfenster: 60 months
|
Total claims paid by Medicare for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
60 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Claims paid by Medicare in 2017 by type of service and service utilization
Zeitfenster: 12 months
|
Claims paid by Medicare for each of following: physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
12 months
|
|
Claims paid by Medicare in 2018 by type of service and service utilization
Zeitfenster: 24 months
|
Claims paid by Medicare for each of following: physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
24 months
|
|
Claims paid by Medicare in 2019 by type of service and service utilization
Zeitfenster: 36 months
|
Claims paid by Medicare for each of following: physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
36 months
|
|
Claims paid by Medicare in 2020 by type of service and service utilization
Zeitfenster: 48 months
|
Claims paid by Medicare for each of following: physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
48 months
|
|
Claims paid by Medicare in 2021 by type of service and service utilization
Zeitfenster: 60 months
|
Claims paid by Medicare for each of following: physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
60 months
|
|
Claims paid by Medicaid in 2017
Zeitfenster: 12 months
|
Claims paid by Medicaid for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
12 months
|
|
Claims paid by Medicaid in 2018
Zeitfenster: 24 months
|
Claims paid by Medicaid for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
24 months
|
|
Claims paid by Medicaid in 2019
Zeitfenster: 36 months
|
Claims paid by Medicaid for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
36 months
|
|
Claims paid by Medicaid in 2020
Zeitfenster: 48 months
|
Claims paid by Medicaid for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
48 months
|
|
Claims paid by Medicaid in 2021
Zeitfenster: 60 months
|
Claims paid by Medicaid for physician services (primary care physician services, specialist services, and services provided by noninstitutional providers), inpatient hospital services, outpatient services, skilled nursing facility, durable medical equipment, hospice, and home health
|
60 months
|
|
Quality-of-care process measures for 2017 based on claims data
Zeitfenster: 12 months
|
Quality-of-care outcome measures based on claims data (including 30-day hospital readmissions, rate of hospitalizations for ambulatory care sensitive admissions, and likelihood of emergency department revisits)
|
12 months
|
|
Quality-of-care process measures for 2018 based on claims data
Zeitfenster: 24 months
|
Quality-of-care outcome measures based on claims data (including 30-day hospital readmissions, rate of hospitalizations for ambulatory care sensitive admissions, and likelihood of emergency department revisits)
|
24 months
|
|
Quality-of-care process measures for 2019 based on claims data
Zeitfenster: 36 months
|
Quality-of-care outcome measures based on claims data (including 30-day hospital readmissions, rate of hospitalizations for ambulatory care sensitive admissions, and likelihood of emergency department revisits)
|
36 months
|
|
Quality-of-care process measures for 2020 based on claims data
Zeitfenster: 48 months
|
Quality-of-care outcome measures based on claims data (including 30-day hospital readmissions, rate of hospitalizations for ambulatory care sensitive admissions, and likelihood of emergency department revisits)
|
48 months
|
|
Quality-of-care process measures for 2021 based on claims data
Zeitfenster: 60 months
|
Quality-of-care outcome measures based on claims data (including 30-day hospital readmissions, rate of hospitalizations for ambulatory care sensitive admissions, and likelihood of emergency department revisits)
|
60 months
|
|
Patient experience
Zeitfenster: 24 months
|
Self-reported measures of patient experience with primary care practitioner and practice
|
24 months
|
|
Patient experience
Zeitfenster: 36 months
|
Self-reported measures of patient experience with primary care practitioner and practice
|
36 months
|
|
Patient experience
Zeitfenster: 60 months
|
Self-reported measures of patient experience with primary care practitioner and practice
|
60 months
|
|
Practitioner and staff experience
Zeitfenster: 24 months
|
Self-reported measures of approaches to delivery of primary care and work experience at practice
|
24 months
|
|
Practitioner and staff experience
Zeitfenster: 48 months
|
Self-reported measures of approaches to delivery of primary care and work experience at practice
|
48 months
|
|
Practice's care delivery
Zeitfenster: 12 months
|
Self-reported measures of practice approaches to delivery of primary care
|
12 months
|
|
Practice's care delivery
Zeitfenster: 24 months
|
Self-reported measures of practice approaches to delivery of primary care
|
24 months
|
|
Practice's care delivery
Zeitfenster: 36 months
|
Self-reported measures of practice approaches to delivery of primary care
|
36 months
|
|
Practice's care delivery
Zeitfenster: 48 months
|
Self-reported measures of practice approaches to delivery of primary care
|
48 months
|
|
Practice's care delivery
Zeitfenster: 60 months
|
Self-reported measures of practice approaches to delivery of primary care
|
60 months
|
Mitarbeiter und Ermittler
Mitarbeiter
Ermittler
- Studienleiter: Deborah Peikes, Ph.D., Mathematica Policy Research
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- CPCPlus2017
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Alle Bedingungen
-
Union Hospital, Tongji Medical College, Huazhong...RekrutierungALL (akute B-lymphoblastische Leukämie)China
-
Nantes University HospitalZurückgezogenCD22+ rezidivierende/refraktäre B-ALLFrankreich
-
University of Erlangen-Nürnberg Medical SchoolRekrutierungAkute lymphoblastische Leukämien (ALL) | Langfristige NachverfolgungDeutschland
-
Ruijin HospitalAktiv, nicht rekrutierendALL (akute B-lymphoblastische Leukämie) | CAR-T-ZelltherapieChina
-
The University of Hong KongNovartis; Queen Mary Hospital, Hong KongNoch keine RekrutierungTransplantation hämatopoetischer Stammzellen, allogen | Ph+ Akute lymphoblastische Leukämie (Ph+ALL) | Blastische Transformation chronischer myeloischer Leukämie | Philadelphia-Chromosom-positive B-Zell akute lymphoblastische Leukämie (Ph+ B-ALL)Hongkong
-
EdiGene (GuangZhou) Inc.The First Affiliated Hospital of Henan University of Science and TechnologyAktiv, nicht rekrutierendRezidivierte oder refraktäre B-Zell-Malignität (NHL/ALL)China
-
Therapeutic Advances in Childhood Leukemia ConsortiumAbbottBeendetAkute lymphatische Leukämie | Rezidivierte pädiatrische ALL | Wiederkehrende pädiatrische ALL | Refraktäres pädiatrisches ALLVereinigte Staaten
-
Stanford UniversityNational Cancer Institute (NCI)AbgeschlossenAkute lymphoblastische B-Zell-Leukämie bei Erwachsenen (ALL) | Ph-positive akute lymphatische Leukämie bei Erwachsenen (ALL) | Rezidivierende akute lymphatische Leukämie bei Erwachsenen (ALL) | Akute lymphoblastische T-Zell-Leukämie bei Erwachsenen (ALL)Vereinigte Staaten
-
University of East AngliaAbgeschlossenEicosapentaensäure | Kardiovaskuläre physiologische Phänomene | Endotheliale Stickoxid-Synthase | Docosahexaensäure (All-Z-Isomer)Vereinigtes Königreich
-
First Affiliated Hospital of Zhejiang UniversityRekrutierung
Klinische Studien zur CPC+ model
-
Boston Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... und andere MitarbeiterRekrutierungBlutung | Frühgeborene | Neugeborenes | HydrozephalusVereinigte Staaten
-
Kepler University HospitalAbgeschlossenHerzstillstandÖsterreich
-
Boston Children's HospitalThe Hospital for Sick Children; Yale University; CURE Children's Hospital, UgandaAktiv, nicht rekrutierendHydrozephalusKanada, Vereinigte Staaten, Uganda
-
Chase Pharmaceuticals Corporation, an affiliate...AbgeschlossenAlzheimer-KrankheitVereinigte Staaten
-
Chase Pharmaceuticals Corporation, an affiliate...AbgeschlossenDemenz vom Alzheimer-TypVereinigte Staaten
-
Indiana UniversityWalther Cancer Institute; Charles Warren Fairbanks Center for Medical EthicsAbgeschlossenKrebs | Bewältigungsfähigkeiten
-
Virginia Commonwealth UniversitySigma Theta Tau International Honor Society of Nursing; Southern Nursing Research...AbgeschlossenSchwangerschaftVereinigte Staaten
-
West Chester University of PennsylvaniaAbgeschlossenPrävention von Stimmstörungen bei LehramtsstudentenVereinigte Staaten
-
Boston Children's HospitalThe Hospital for Sick Children; Penn State University; CURE Children's Hospital...Aktiv, nicht rekrutierend
-
National Jewish HealthMyCardioAbgeschlossen